Akèy › Leksemi mieloïd egi › New Jersey › Clifton
Etid klinik pou Leksemi mieloïd egi nan Clifton, NJ
12 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Clifton (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Ap rekriteFaz 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Ap rekriteFaz 3
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Ap rekriteFaz 3
- Hackensack University Medical Center, Hackensack · 7 mi lwen
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Ap rekriteFaz 2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi lwen
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- Hackensack University Medical Center, Hackensack · 7 mi lwen
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Ap rekriteFaz 3
- Hackensack University Medical Center, HMH, Hackensack · 7 mi lwen
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Ap rekriteFaz 2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- Hackensack University Medical Center, Hackensack · 7 mi lwen
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Ap rekriteFaz 2/3
- John Theurer Cancer Center / Hackensack University, Hackensack · 7 mi lwen
Phase IB/II of CPX-351 for Relapse Prevention in AML
Ap rekriteFaz 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Ap rekriteFaz 1
- Hackensack University Medical Center, Hackensack · 7 mi lwen
Etid Leksemi mieloïd egi nan lòt vil
- Houston, TX85 etid
- New York City, NY51 etid
- Boston, MA44 etid
- Seattle, WA41 etid
- Baldwin Park, CA40 etid
- Columbus, OH35 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Atlanta, GA31 etid
- Tampa, FL29 etid
- Chicago, IL26 etid
- Portland, OR25 etid
Lòt etid nan Clifton
- Kansè Poumon ki pa ti selil24 etid
- Kansè (tout kalite)15 etid
- Myelom Miltip14 etid
- Kansè Metastatik12 etid
- Kansè nan tete12 etid
- Kansè pwostat12 etid
- Kansè ovè11 etid
- Kansè poumon10 etid
- Kansè kolorektal8 etid
- Karsinòm selil skuamèz tèt ak kou8 etid
- Kansè Endomèt8 etid
- Ensifizyans kadyak8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.